AI for Clinical Trial Patient Matching — Accelerating Enrollment and Improving Access (Updated 2026)
OVERVIEWAI-powered clinical trial matching systems are demonstrating significant impact on trial enrollment and patient access to experimental therapies. Systems like those developed by Dyania (in partnership with Cleveland Clinic) use machine learning to match patient characteristics, medical history, and biomarkers with trial eligibility criteria, accelerating both patient identification and trial recruitment. Clinical trial matching represents a high-impact AI use case because it solves a genuine bottleneck: many patients never learn about trials for which they're eligible, and trial sites struggle with recruitment. AI matching systems can screen electronic health records at scale, identifying eligible patients and facilitating outreach. The Cleveland Clinic-Dyania partnership earned a 2026 Gartner Innovation Award, signaling growing industry recognition of trial matching as a mature AI application. The success of trial-matching AI also demonstrates that AI's highest-value applications in healthcare may not be autonomous clinical decision-making, but rather information coordination and matching tasks that leverage AI's ability to process large datasets and identify patterns humans might miss. As trial matching scales, it will improve patient access to cutting-edge treatments while accelerating clinical research. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.